Published on 26/10/2009
Big Brother star Jade Goody's public battle with
cervical cancer served to increase awareness among British women about the importance of screenings, experts believe.
The NHS reported that last year the number of women aged between 25 and 64 being screened for cervical abnormalities rose by 12 per cent.
According to the figures, the rise in screening was more prominent among younger age groups, with coverage among 25 to 49 year-olds who had undergone smears in the previous three years growing from 69.3 per cent in March 2008 to 72.5 per cent the same time this year.
As a popular TV personality, Jade's experience and untimely death urged younger women to seek testing and follow-up appointments in order to reduce their risk.
Rob Music, director of
cancer charity Jo's Trust, said: "Certainly for the 25 to 34-year olds we need to look at different ways of actually reaching that particular age group.
"Predominantly it's through increased awareness of
cervical cancer ... The way Jade told her story so publicly did have an impact or was a major reason why there was an increase."
Evidence shows that 99 per cent of all cervical cancers are caused by the human papillomavirus (HPV).
© ActiveQuote Health Ltd. 2009
Categories: Medical
Related Health Insurance News Articles
12/08/2011Number of people waiting more than 6 weeks for NHS tests quadruplesDespite pledges by David Cameron to keep waiting times low, newly released figures indicate that the number of people waiting more than six weeks for key NHS tests has quadrupled in one year*. In June 2010...
24/08/2011Labiaplasty should be left to the private medical sectorGPs should not refer women for labiaplasty on the NHS who are in good health but concerned about the appearance of their genitalia, experts say. Specialists at a Central London hospital say they have received...
29/09/2010Britons wait six years for chronic pain treatmentSufferers of chronic pain may want to seek out private medical cover in order to avoid lengthy waits for effective treatment. According to a new study sponsored by drug company Pfizer, Britain's eight...
15/11/2010Private medical cover to increase following Nice decision on Avastin?The NHS regulator the National Institute for Health and Clinical Excellence (NICE) has confirmed it is not approving funding for cancer drug Avastin, something that could lead to more people taking out ...
30/11/2010More people to take out private medical cover after Nice rejects kidney cancer drug?A greater number of people may be considering taking out private medical cover following the rejection of a drug to treat kidney cancer by the NHS regulator. The National Institute of Health and Clinical...